Dr. John Brownstein, co-founder of Circulation, was faced with getting vaccines to patients. What he discovered was how a company like Uber could be the answer. This video was produced by the MM&M Content Lab in partnership with Klick Health. Make the journey.
Disease awareness ads can boost drug sales; AstraZeneca's experimental asthma drug cuts steroid use; FDA approves Regeneron and Sanofi's RA drug
The chip-in-a-pill combines antipsychotic Abilify with an ingestible sensor made by Proteus.
Recent grads aren't afraid to voice their expectations, and agencies are responding with new programs and policies.
This includes Sarepta Therapeutics' Exondys 5 and Vertex Pharmaceuticals' Orkambi.
Brian Goff is expected to replace Carsten Thiel in June. The drugmaker said Tuesday that Thiel along with several other execs would be leaving the firm.
An FDA advisory committee is expected to decide Wednesday whether to recommend neratinib for approval.
Amgen's osteoporosis drug set back by safety issue; new FDA digital biz to hire 13 engineers; Celgene's MS drug bests Avonex in trial
Siri and accessibility features take center stage in ads for Global Accessibility Awareness Day.
Five sector pros discuss adapting to patient-centricity and how pinpointing patient needs leads to success.
Keytruda gets two new FDA approvals; lawmakers aim to speed up approval of generics; Incyte uses soap opera to spread rare-disease awareness
Here you'll find everything from our May 2017 issue, including our Top 40 Transformers, deep dive into autoimmune drugs, and more.
In general, physicians believe that information provided by pharma companies is difficult to find and lacking in science.
Docs spend little time telling patients about cancer costs; Shire to file hereditary angioedema drug with the FDA by 2018; Philips CEO on access obstacles
Robert Califf stepped down from his role as FDA commissioner in January.
FDA requires boxed warning for J&J's Invokana; Amazon to reportedly hire GM to enter pharmacy industry; WannCry ransomware affects some health organizations
The ad-tax deduction is likely once again on the table.
A New York county sues drugmakers over opioid marketing; AstraZeneca files suit against GSK exec; Thermo Fisher acquires biologics firms
The former FDA commissioner said marketers need to focus on ensuring that off-label promotion is "non-misleading."
- Study: One-third of docs trust pharma content on HCP sites
- Five things for pharma marketers to know: Wednesday, May 17, 2017
- Five things for pharma marketers to know: Monday, May 22, 2017
- Five things for pharma marketers to know: Tuesday, May 23, 2017
- Five things for pharma marketers to know: Friday, May 19, 2017
- Nearly every $100,000 drug approved in the last three years was for a rare disease
- Alexion hires new chief commercial officer
- Otsuka, Proteus refile their sensor-enabled drug
- The class of 2017 wants it all: Work-life balance and a well-paid future
- The FDA says Puma's breast-cancer drug is effective, cautions about side effects
Live at MM&M Transforming Healthcare
In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.
One executive referred to AI as a "black box" and as the "Tower of Babel."
Execs stressed the importance of collaboration, consumer-mindedness.
The artificial pancreas can provide value to the health system.
MM&M honors 40 upstarts and veteran innovation gurus.
For the first time MM&M honors a group of 10 agency execs.